Listen to FDA Drug Safety Podcast, FDA’s preliminary evaluation has not found evidence that use of GLP-1 RAs causes suicidal thoughts/actions.
Similar Posts
US Specialty Formulations LLC. Allentown, PA. 483 issued 1/14/2026
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 1/14/2026
Short Title (70 char) US Specialty Formulations LLC. Allentown, PA. 483 issued 1/14/2026
FEI Number 3010680515
Firm Name US Specialty Formulations LLC
Record Type 483
State PA
Establishment Type OutsouEmpower Clinic Services LLC dba Empower Pharma. Houston, TX. 483 issued 12/14/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 12/14/2025
Short Title (70 char) Empower Clinic Services LLC dba Empower Pharma. Houston, TX. 483 issued 12/14/2025
FEI Number 3011887629
Firm Name Empower Clinic Services LLC dba Empower Pharma
Record Type 483Clinical trials for medicines: manage your authorisation, report safety issues
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Manufacturer’s Online Reporting Environment (MORE)
A digital platform designed to facilitate the reporting, monitoring, and management of medical device incidents.
Guangxi Yulin Pharmaceutical Group Co. Ltd. – 710422 – 09/30/2025
CGMP/Finished Pharmaceuticals/AdulteratedFriendly’s Issues Allergy Alert on Undeclared Soy/Wheat in Friendly’s Cookies & Cream Ice Cream
Friendly’s Ice Cream is voluntarily recalling a limited quantity (324 cartons) of 48 fl. oz. Cookies & Cream ice cream because of undeclared soy and wheat. The recalled product was mistakenly packaged in Friendly’s Vanilla Bean ice cream cartons with a Cookies & Cream lid. People who have an allergy